Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 21217B100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Janus Henderson Group PLC 13G | 7.9% |
2/17/2026
Event 12/31/2025
|
||
|
Balyasny Asset Management L.P.
13G/A
|
7.1% |
8/14/2026
Event 6/30/2026
|
||
| Balyasny Asset Management L.P. | 7.1% | |||
| Bam GP LLC | 7.1% | |||
| Balyasny Asset Management Holdings LP | 7.1% | |||
| Dames GP LLC | 7.1% | |||
| Dmitry Balyasny | 7.1% | |||
| BlackRock, Inc. 13G | 6.3% |
7/27/2026
Event 6/30/2026
|
||
|
Franklin Resources, Inc.
13G/A
|
6.2% |
1/29/2026
Event 12/31/2025
|
||
| Franklin Resources, Inc. | 6.2% | |||
| Charles B. Johnson | 0% | |||
| Rupert H. Johnson, Jr. | 0% | |||
| Franklin Advisers, Inc. | 6.2% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
Sectoral Asset Management Inc
13G/A
|
4.99% |
2/14/2025
Event 12/31/2024
|
||
| Sectoral Asset Management Inc | 4.2% | |||
| Jerome G. Pfund | 4.99% | |||
|
RA Capital Management, L.P.
13G/A
|
4.0% |
5/15/2026
Event 3/31/2026
|
||
| RA Capital Management, L.P. | 4.0% | |||
| Peter Kolchinsky | 4.0% | |||
| Rajeev Shah | 4.0% | |||
| RA Capital Healthcare Fund, L.P. | 4.0% | |||
|
Perceptive Advisors LLC
13G/A
|
3.2% |
8/14/2025
Event 6/30/2025
|
||
| Perceptive Advisors LLC | 3.2% | |||
| Joseph Edelman | 3.2% | |||
| Perceptive Life Sciences Master Fund, Ltd. | 3.2% | |||
|
Millennium Management LLC
13G/A
|
2.8% |
7/17/2026
Event 6/30/2026
|
||
| Millennium Management LLC | 2.8% | |||
| Millennium Group Management LLC | 2.8% | |||
| Israel A. Englander | 2.8% | |||
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 43.0 | $577.00 |
| 2026 Q2 | 104 | 30.6 M | $501 M |
| 2026 Q1 | 91 | 30.6 M | $399 M |
| 2025 Q4 | 83 | 29.6 M | $338 M |
| 2025 Q3 | 63 | 17.5 M | $206 M |
| 2025 Q2 | 72 | 13.9 M | $55.4 M |
| 2025 Q1 | 64 | 15.3 M | $107 M |
| 2024 Q4 | 63 | 15.8 M | $231 M |
| 2024 Q3 | 54 | 13.7 M | $258 M |
| 2024 Q2 | 52 | 13.0 M | $229 M |